Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 49

Results For "Cialis"

641 News Found

Unilever, Genomatica form venture to develop palm oil based alternatives
News | June 20, 2022

Unilever, Genomatica form venture to develop palm oil based alternatives

With $120m jointly invested in the newly-formed initiative, and with other strategic investors expected to join, the venture will develop an alternative, plant-based ingredient using biotechnology


Cipla signs agreement for acquisition of 21.05% stake in Achira Labs
News | June 20, 2022

Cipla signs agreement for acquisition of 21.05% stake in Achira Labs

This investment will facilitate a Cipla entity's strategic participation in the Poe diagnostics and AMR space through the design, development, and manufacturing of microfluidics-based technologies


NHA and NASSCOM organised a conclave on Ayushman Bharat Digital Mission
Policy | June 15, 2022

NHA and NASSCOM organised a conclave on Ayushman Bharat Digital Mission

The Ayushman Bharat Digital Mission (ABDM) aims to replicate this success in healthcare delivery by building an equitable, accessible and inclusive ecosystem


Modi Inaugurates hospital complex and CoE in South Gujarat
Public Health | June 11, 2022

Modi Inaugurates hospital complex and CoE in South Gujarat

Centre of Excellence at Kharel comprises Skill-building Centre and Primary, Secondary and Higher Secondary schools


Apollo Speciality Hospitals, Vanagaram organises vertigo awareness bicycle rally
Healthcare | June 06, 2022

Apollo Speciality Hospitals, Vanagaram organises vertigo awareness bicycle rally

The rally attracted around 250 riders, including professionals and amateurs.


Mitsubishi Tanabe Pharma America presents 48-week results from phase 3 safety clinical study of Radicava ORS
News | June 03, 2022

Mitsubishi Tanabe Pharma America presents 48-week results from phase 3 safety clinical study of Radicava ORS

Radicava ORS was approved by the U.S. Food and Drug Administration (FDA) on May 12, 2022


GSK to acquire clinical-stage biopharmaceutical company Affinivax for US$ 3.3 billion
News | June 03, 2022

GSK to acquire clinical-stage biopharmaceutical company Affinivax for US$ 3.3 billion

GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones


BGS Gleneagles launches its refurbished advanced emergency & trauma center
Healthcare | June 02, 2022

BGS Gleneagles launches its refurbished advanced emergency & trauma center

120+ members of multi-disciplinary medical team are trained to provide seamless, outcome driven trauma and emergency care


US FDA accepts new drug application filed by Avillion for AstraZeneca's PT027
Drug Approval | June 01, 2022

US FDA accepts new drug application filed by Avillion for AstraZeneca's PT027

Avillion announces expansion of partnership with AstraZeneca on PT027 and will fund and execute a new Phase 3b study


ASG Eye Hospitals opens unit in Dombivli, Maharashtra
Hospitals | May 26, 2022

ASG Eye Hospitals opens unit in Dombivli, Maharashtra

The new facility at Dombivli is the fifth ASG Eye Hospital in Maharashtra